Skip to main
BRKR
BRKR logo

Bruker (BRKR) Stock Forecast & Price Target

Bruker (BRKR) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 20%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Bruker Corp is forecasting adjusted earnings per share (EPS) growth between 0% to 3% as reported, or 5% to 8% on a constant currency basis, indicating a resilience in profitability despite a downward revision from earlier expectations. The company reported an improvement in adjusted gross margins by 10 basis points to 51.3%, highlighting effective cost management and operational efficiency. Additionally, management anticipates a recovery in fiscal year 2026, post Tariff and Administrative & General (A&G) impacts, which supports a positive outlook for future growth.

Bears say

Bruker Corp has lowered its operating margin expectations for FY25 to flat, a significant drop from a prior forecast of an increase of 140 basis points, reflecting concerns about profitability. Additionally, management anticipates a decline in organic revenue for the second quarter due to softer conditions in the U.S. and China, along with delays in U.S.-produced revenue. Furthermore, the company's 2025 outlook for organic growth has been reduced to a range of 0% to 2%, falling short of Street expectations and indicating potential stagnation in core operations.

Bruker (BRKR) has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 20% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Bruker and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Bruker (BRKR) Forecast

Analysts have given Bruker (BRKR) a Buy based on their latest research and market trends.

According to 10 analysts, Bruker (BRKR) has a Buy consensus rating as of Oct 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $51, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $51, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Bruker (BRKR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.